PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
Smit J, Borm FJ, Niemeijer AN, Huisman MC, Hoekstra OS, Boellaard R, Oprea-Lager DE, Vugts DJ, van Dongen GAMS, de Wit-van der Veen BJ, Thunnissen E, Smit EF, de Langen AJ.
Smit J, et al. Among authors: boellaard r.
J Nucl Med. 2022 May;63(5):686-693. doi: 10.2967/jnumed.121.262473. Epub 2021 Aug 12.
J Nucl Med. 2022.
PMID: 34385342
Free article.